Verrica Pharmaceuticals Inc.

Last updated September 27, 2026

Organization details

Legal name
Verrica Pharmaceuticals Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
West Chester
Headquarters state / province
Pennsylvania
Headquarters country
United States
Fiscal year end
December
Ticker symbol
VRCA
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001660334
EIN
46-3137900

Board of directors

Chief executives

Jayson Rieger · CEO and President
Since November 2024
100 CEO score

Outstanding · grade A+

Out of 100, from shareholder return, dividends, growth and acquisitions.

Partial: only 20% of the scoring weight is on file.

Revenue growth 20%
100

163.5% a year in revenue

20% of the scoring weight is on file. Figures cover December 2023 – December 2025.

Ted White · President and CEO
Until November 2024 · Former

Director election results

Annual meeting of June 5, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

3 of this board's directors also sit on 5 other boards. 5 are in the same sector.

Network of Verrica Pharmaceuticals Inc.'s board connections Candel Therapeutics Inc. Candel Therapeutics In... Acumen Pharmaceuticals Inc. Acumen Pharmaceuticals... Liquidia Corporation Liquidia Corporation SIGA Technologies Inc. SIGA Technologies Inc. Taysha Gene Therapies Inc. Taysha Gene Therapies... Diem Nguyen Diem Nguyen John A. Stalfort III John A. Stalfort III Paul B. Manning Paul B. Manning Verrica Pharmaceuticals In...
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$18,172,997
12 purchases by 5 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Aug 18, 2026 Kirby John J. Officer (Interim CFO) Open-market purchase +5,000 $4.93 $24,650
Aug 18, 2026 Rosenberg Noah L. Officer (CMO) Open-market purchase +2,030 $4.92 $9,988
Aug 17, 2026 Rosenberg Noah L. Officer (CMO) Open-market purchase +4,200 $4.91 $20,622
Aug 17, 2026 Zawitz David Officer (Chief Operating Officer) Open-market purchase +6,000 $4.98 $29,880
Aug 17, 2026 Jayson Rieger Director, Officer (CEO and President) Open-market purchase +5,000 $4.91 $24,550
Aug 14, 2026 Jayson Rieger Director, Officer (CEO and President) Open-market purchase +20,000 $5.06 $101,200
Dec 23, 2025 Kirby John J. Officer (Interim CFO) Grant or award +10,000 — —
Nov 25, 2025 Rosenberg Noah L. Officer (CMO) Open-market purchase +2,357 $4.24 $9,994
Nov 25, 2025 Kirby John J. Officer (Interim CFO) Open-market purchase +3,536 $4.24 $14,993
Nov 25, 2025 Zawitz David Officer (Chief Operating Officer) Open-market purchase +10,000 $4.24 $42,400
Nov 25, 2025 Jayson Rieger Director, Officer (CEO and President) Open-market purchase +94,311 $4.24 $399,879
Nov 25, 2025 Paul B. Manning Director, 10% owner Open-market purchase +1,375,380 $4.24 $5,831,611
Nov 25, 2025 Paul B. Manning Director, 10% owner Open-market purchase +2,750,762 $4.24 $11,663,231
Mar 17, 2025 Hayes Christopher G. Officer (CHIEF LEGAL OFFICER) Open-market sale −4,315 $0.65 $2,805
Nov 26, 2024 Jayson Rieger Director, Officer (CEO and President) Gift +50,000 — —

Organizations in the same sector, closest in location and size first.

Questions about Verrica Pharmaceuticals Inc.

Who is the CEO of Verrica Pharmaceuticals Inc.?

Jayson Rieger has been Verrica Pharmaceuticals Inc.'s CEO and President since November 2024.

How many directors are on Verrica Pharmaceuticals Inc.'s board?

Verrica Pharmaceuticals Inc.'s board has 10 directors: Charles Frantzreb, Craig Ballaron, Diem Nguyen, Gavin Corcoran, Jayson Rieger, John A. Stalfort III, Lawrence Eichenfield, Mark A. Prygocki Sr., Paul B. Manning and Ted White.

Are Verrica Pharmaceuticals Inc. insiders buying or selling shares?

Over the last 12 months, Verrica Pharmaceuticals Inc. insiders bought $18.2 million of shares in 12 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="verrica-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.